Drug Trial Radar · NCT07358858
A Food Effect Study of QLS1410 in Healthy Chinese Adults
Last checked: Nov 19, 2026Latest source record: Jan 22, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Not yet recruiting
Enrollment
12
Planned (sponsor's estimate)
Start
Jan 23, 2026
Primary completion
Feb 7, 2026
Study completion Feb 7, 2026
Sponsor
- Lead sponsor
- Qilu Pharmaceutical Co., Ltd.Industry
- Sponsor type
- Industry
- First posted
- Jan 22, 2026
Design
- Study type
- Interventional
- Phase
- Phase 1
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years, up to 55 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
This study is aimed to evaluate the effect of food on pharmacokinetics of QLS1410 in healthy Chinese adults.
Conditions
- Uncontrolled Hypertension
Interventions
QLS1410Drug
QLS1410 tablets
Primary outcomes
What the sponsor says the trial is designed to measure.
- AUC0-∞Time frame: 0 to 96 hours
- Area under the curve plasma concentration from time zero to Time of Last Quantifiable ConcentrationTime frame: 0 to 96 hours
- Maximum observed plasma concentrationTime frame: 0 to 96 hours
Locations
No sites are listed on the registry yet.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.